| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
INSERM, U-458, Hôpital R. Debré (C.S., L.P., T.M.), 75019 Paris; and INSERM, U-129, Institut Cochin de Génétique Moléculaire, Université René Descartes (C.S., O.C., R.B., P.A., P.C.), 75014 Paris, France
Address all correspondence and requests for reprints to: Dr. Christine Perret, INSERM, U-129, ICGM, Université René Descartes, 24 rue du Faubourg Saint Jacques, 75014 Paris, France. E-mail: perret{at}cochin inserm.fr.
The promoter of the calbindin-D 9k (CaBP9k) gene, previously analyzed in transgenic mice, contains all of the information necessary for expression of a transgene similar to the endogenous gene and also for an appropriate response to vitamin D. In the present study we first investigated the role of a putative vitamin D-responsive element (9k/VDRE), located at nucleotides -489 to -445 on the rat CaBP9k promoter gene, using transgenic mice. As expected, the pattern of transgene expression in mice carrying this putative VDRE mutated in its whole promoter context was similar to that in mice bearing the wild-type sequence. These transgenic mice also responded to 1,25-dihydroxyvitamin D3 in the same way as those bearing the wild-type transgene and as those carrying a transgene with a large deletion (from -2894 to -117) eliminating the putative 9k/VDRE. Thus, the putative 9k/VDRE is not required for the control of rat CaBP9k gene expression by vitamin D in vivo. We also found that responsiveness to 1,25-dihydroxyvitamin D3 depends on the site at which the transgene is integrated into the host genome, in a tissue-specific manner. These data together with the fact that vitamin D-responsive sequences are present in a two-module region (from -3731 to -2894 and/or -117 to +365) and that this region does not contain any classical VDRE show that the CaBP9k gene is submitted to a nonconventional control by vitamin D.
This article has been cited by other articles:
 |
|
 |
|
  Y. Song and J. C. Fleet Intestinal Resistance to 1,25 Dihydroxyvitamin D in Mice Heterozygous for the Vitamin D Receptor Knockout Allele Endocrinology, March 1, 2007; 148(3): 1396 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Kutuzova, S. Akhter, S. Christakos, J. Vanhooke, C. Kimmel-Jehan, and H. F. DeLuca Calbindin D9k knockout mice are indistinguishable from wild-type mice in phenotype and serum calcium level PNAS, August 15, 2006; 103(33): 12377 - 12381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, A. Klopot, J.-N. Freund, L. N. Dowling, S. D. Krasinski, and J. C. Fleet Control of differentiation-induced calbindin-D9k gene expression in Caco-2 cells by cdx-2 and HNF-1{alpha} Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G943 - G953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Peleg, M. Uskokovic, A. Ahene, B. Vickery, and Z. Avnur Cellular and Molecular Events Associated with the Bone-Protecting Activity of the Noncalcemic Vitamin D Analog Ro-26-9228 in Osteopenic Rats Endocrinology, May 1, 2002; 143(5): 1625 - 1636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. C. Li, M. J. G. Bolt, L.-P. Cao, and M. D. Sitrin Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E558 - E564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Muller, J. G. J. Hoenderop, C. H. van Os, and R. J. M. Bindels The epithelial calcium channel, ECaC1: molecular details of a novel player in renal calcium handling Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1329 - 1335. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
